Mylan Launches Generic Antara® Capsules

Mylan Inc. (Nasdaq:MYL) today announced that its subsidiary Mylan Pharmaceuticals has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news